Involvement of brain oxidation in the cognitive impairment in a triple transgenic mouse model of Alzheimer's disease: Noninvasive measurement of the brain redox state by magnetic resonance imaging

Free Radical Research

Volumn 47, Issue 9, 2013, Pages 731-739

  Ishihara, Y ^a,b   Itoh, K ^b   Mitsuda, Y ^b   Shimada, T ^b   Kubota, T ^b   Kato, C ^b   Song, S Y ^b   Kobayashi, Y ^c   Mori Yasumoto, K ^d   Sekita, S ^d   Kirino, Y ^b   Yamazaki, T ^a   Shimamoto, N ^b  

^a HIROSHIMA UNIVERSITY   (Japan)

^b TOKUSHIMA BUNRI UNIVERSITY   (Japan)

^c KYOTO UNIVERSITY   (Japan)

^d Laboratory of Pharmacognosy and Natural Products Chemistry Kagawa School of Pharmaceutical Sciences   (Japan)

Author keywords

Alzheimer's disease; Brain oxidation; Cognitive function; MRI; Oxidative stress

Indexed keywords

ALPHA TOCOPHEROL; GLUTATHIONE; GLUTATHIONE DISULFIDE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN CORTEX; BRAIN TISSUE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; HIPPOCAMPUS; LIPID PEROXIDATION; MAZE TEST; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; TRANSGENIC MOUSE; VITAMIN SUPPLEMENTATION; ANIMAL; BRAIN; DISEASE MODEL; GENETICS; HUMAN; METABOLISM; MILD COGNITIVE IMPAIRMENT; PATHOLOGY; RADIOGRAPHY;

MUS; MUS MUSCULUS;

ALZHEIMER DISEASE; ANIMALS; BRAIN; CEREBRAL CORTEX; DISEASE MODELS, ANIMAL; HUMANS; LIPID PEROXIDATION; MAGNETIC RESONANCE IMAGING; MICE; MICE, TRANSGENIC; MILD COGNITIVE IMPAIRMENT; OXIDATIVE STRESS;

EID: 84882396248     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.3109/10715762.2013.818218     Document Type: Article

References (41)

1. Droge W. Free radicals in the physiological control of cell function. Physiol Rev 2002; 82: 47-95.
2. Kalaria RN, Maestre GE, Arizaga R, Friedland RP, Galasko D, Hall K, et al. Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors. Lancet Neurol 2008; 7: 812-826.
3. Selkoe DJ. Alzheimer's disease: genes, proteins, and therapy. Physiol Rev 2001; 81: 741-766.
4. Aksenov MY, Markesbery WR. Changes in thiol content and expression of glutathione redox system genes in the hippocampus and cerebellum in Alzheimer's disease. Neurosci Lett 2001; 302: 141-145.
5. Sayre LM, Zelasko DA, Harris PL, Perry G, Salomon RG, Smith MA. 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease. J Neurochem 1997; 68: 2092-2097.
6. Wang J, Xiong S, Xie C, Markesbery WR, Lovell MA. Increased oxidative damage in nuclear and mitochondrial DNA in Alzheimer's disease. J Neurochem 2005; 93: 953-962.
7. Lovell MA, Markesbery WR. Oxidative damage in mild cognitive impairment and early Alzheimer's disease. J Neurosci Res 2007; 85: 3036-3040.
8. Baldeiras I, Santana I, Proenca MT, Garrucho MH, Pascoal R, Rodrigues A, et al. Oxidative damage and progression to Alzheimer's disease in patients with mild cognitive impairment. J Alzheimers Dis 2010; 21: 1165-1177.
9. Nunomura A, Castellani RJ, Zhu X, Moreira PI, Perry G, Smith MA. Involvement of oxidative stress in Alzheimer disease. J Neuropathol Exp Neurol 2006; 65: 631-641.
10. Sung S, Yao Y, Uryu K, Yang H, Lee VM, Trojanowski JQ, Pratico D. Early vitamin E supplementation in young but not aged mice reduces Abeta levels and amyloid deposition in a transgenic model of Alzheimer's disease. Faseb J 2004; 18: 323-325.
11. Nishida Y, Yokota T, Takahashi T, Uchihara T, Jishage K, Mizusawa H. Deletion of vitamin E enhances phenotype of Alzheimer disease model mouse. Biochem Biophys Res Commun 2006; 350: 530-536.
12. Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, et al. Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 2003; 39: 409-421.
13. Resende R, Moreira PI, Proenca T, Deshpande A, Busciglio J, Pereira C, Oliveira CR. Brain oxidative stress in a triple-transgenic mouse model of Alzheimer disease. Free Radic Biol Med 2008; 44: 2051-2057.
14. McKee AC, Carreras I, Hossain L, Ryu H, Klein WL, Oddo S, et al. Ibuprofen reduces Abeta, hyperphosphorylated tau and memory defi cits in Alzheimer mice. Brain Res 2008; 1207: 225-236.
15. Fujii HG, Sato-Akaba H, Emoto MC, Itoh K, Ishihara Y, Hirata H. Noninvasive mapping of the redox status in septic mouse by in vivo electron paramagnetic resonance imaging. Magn Reson Imaging 2013; 31: 130-138.
16. Anzai K, Saito K, Takeshita K, Takahashi S, Miyazaki H, Shoji H, et al. Assessment of ESR-CT imaging by comparison with autoradiography for the distribution of a bloodbrain- barrier permeable spin probe, MC-PROXYL, to rodent brain. Magn Reson Imaging 2003; 21: 765-772.
17. Lee MC, Shoji H, Miyazaki H, Yoshino F, Hori N, Toyoda M, et al. Assessment of oxidative stress in the spontaneously hypertensive rat brain using electron spin resonance (ESR) imaging and in vivo L-Band ESR. Hypertens Res 2004; 27: 485-492.
18. Sano H, Matsumoto K, Utsumi H. Synthesis and imaging of blood-brain-barrier permeable nitroxyl-probes for free radical reactions in brain of living mice. Biochem Mol Biol Int 1997; 42: 641-647.
19. Itoh O, Obara H, Aoyama M, Ohya H, Kamada H. Development of a functional spin probe for in vivo ESR measurement. Anal Sci 2001; 17: i1515-i1517.
20. Vatassery GT, Lam C, Smith WE, Quach HT. Apolipoprotein E exerts selective and diff erential control over vitamin E concentrations in diff erent areas of mammalian brain. J Neurosci Res 2006; 84: 1335-1342.
21. Ishihara Y, Shiba D, Shimamoto N. Enhancement of DMNQinduced hepatocyte toxicity by cytochrome P450 inhibition. Toxicol Appl Pharmacol 2006; 214: 109-117.
22. Ishihara Y, Kawami T, Ishida A, Yamazaki T. Tributyltin induces oxidative stress and neuronal injury by inhibiting glutathione S-transferase in rat organotypic hippocampal slice cultures. Neurochem Int 2012; 60: 782-790.
23. Halagappa VK, Guo Z, Pearson M, Matsuoka Y, Cutler RG, Laferla FM, Mattson MP. Intermittent fasting and caloric restriction ameliorate age-related behavioral defi cits in the triple-transgenic mouse model of Alzheimer's disease. Neurobiol Dis 2007; 26: 212-220.
24. Ichikawa H, Itoh K. Blood-arachnid barrier disruption in experimental rat meningitis detected using gadoliniumenhancement ratio imaging. Brain Res 2011; 1390: 142-149.
25. Roberts TPL, Noseworthy MD. Contrast agents for magnetic resonance imaging. In: Jackson A, Buckley DL, Parker GJM (eds.). Dynamic contrast-enhanced magnetic resonance imaging in oncology. Heidelberg: Springer; 2005. pp. 23-37.
26. Burgmans S, van de Haar HJ, Verhey FR, Backes WH. Amyloid- a interacts with blood-brain barrier function in dementia: a systematic review. J Alzheimers Dis 2013; 35: 859-873.
27. Deane R, Zlokovic BV. Role of the blood-brain barrier in the pathogenesis of Alzheimer's disease. Curr Alzheimer Res 2007; 4: 191-197.
28. Markesbery WR, Lovell MA. Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease. Neurobiol Aging 1998; 19: 33-36.
29. Aksenov MY, Aksenova MV, Butterfi eld DA, Geddes JW, Markesbery WR. Protein oxidation in the brain in Alzheimer's disease. Neuroscience 2001; 103: 373-383.
30. Hamilton A, Holscher C. The eff ect of ageing on neurogenesis and oxidative stress in the APP(swe)/PS1(deltaE9) mouse model of Alzheimer's disease. Brain Res 2012; 1449: 83-93.
31. Pratico D, Uryu K, Leight S, Trojanoswki JQ, Lee VM. Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis. J Neurosci 2001; 21: 4183-4187.
32. Traber MG, Burton GW, Hamilton RL. Vitamin E traffi cking. Ann N Y Acad Sci 2004; 1031: 1-12.
33. Yokota T, Igarashi K, Uchihara T, Jishage K, Tomita H, Inaba A, et al. Delayed-onset ataxia in mice lacking alpha -tocopherol transfer protein: model for neuronal degeneration caused by chronic oxidative stress. Proc Natl Acad Sci U S A 2001; 98: 15185-15190.
34. Hyodo F, Chuang KH, Goloshevsky AG, Sulima A, Griffi ths GL, Mitchell JB, et al. Brain redox imaging using blood-brain barrier-permeable nitroxide MRI contrast agent. J Cereb Blood Flow Metab 2008; 28: 1165-1174.
35. Atwood CS, Perry G, Zeng H, Kato Y, Jones WD, Ling KQ, et al. Copper mediates dityrosine cross-linking of Alzheimer's amyloid-beta. Biochemistry 2004; 43: 560-568.
36. Siegel SJ, Bieschke J, Powers ET, Kelly JW. The oxidative stress metabolite 4-hydroxynonenal promotes Alzheimer protofi bril formation. Biochemistry 2007; 46: 1503-1510.
37. Smith DG, Cappai R, Barnham KJ. The redox chemistry of the Alzheimer's disease amyloid beta peptide. Biochim Biophys Acta 2007; 1768: 1976-1990.
38. Tabner BJ, El-Agnaf OM, Turnbull S, German MJ, Paleologou KE, Hayashi Y, et al. Hydrogen peroxide is generated during the very early stages of aggregation of the amyloid peptides implicated in Alzheimer disease and familial British dementia. J Biol Chem 2005; 280: 35789-35792.
39. Wu A, Ying Z, Gomez-Pinilla F. The interplay between oxidative stress and brain-derived neurotrophic factor modulates the outcome of a saturated fat diet on synaptic plasticity and cognition. Eur J Neurosci. 2004; 19: 1699-1707.
40. Wu A, Ying Z, Gomez-Pinilla F. Vitamin E protects against oxidative damage and learning disability after mild traumatic brain injury in rats. Neurorehabil Neural Repair 2010; 24: 290-298.
41. Mangialasche F, Xu W, Kivipelto M, Costanzi E, Ercolani S, Pigliautile M, et al. Tocopherols and tocotrienols plasma levels are associated with cognitive impairment. Neurobiol Aging 2012; 33: 2282-2290.